Is CVE-2023-38958 actively exploited?

CVE-2023-38958 has no public evidence of in-the-wild exploitation as of 2024-11-21.

What is the CVSS score for CVE-2023-38958?

CVE-2023-38958 has a CVSS score of 5.3 (MEDIUM severity). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N.

How do I patch CVE-2023-38958?

Patch guidance is available from zkteco security advisories. CVEDatabase generates AI-assisted remediation guidance on demand for CVE-2023-38958.

Which products are affected by CVE-2023-38958?

1 product: zkteco bioaccess ivs.

CVE-2023-38958 - remediation guidance & executive summary

Description

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

CVSS Metrics

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Attack Vector: network
Complexity: low
Privileges: none
User Action: none
Scope: unchanged
Confidentiality: none
Integrity: low
Availability: none
Weaknesses: CWE-863 · Incorrect Authorization

Metadata

Primary Vendor: ZKTECO
Published: 8/3/2023
Last Modified: 11/21/2024
Source: NIST NVD
Note: Verify all details with official vendor sources before applying patches.

CVE-2023-38958

Description

CVSS Metrics

Metadata

Affected Products

Remediation Guidance

Executive Summary